The pharmacological profile of norgestimate, a new orally active progestin.
D000818:Animals; D002369:Castration; D003276:Contraceptives, Oral / Q000494:pharmacology*; D004305:Dose-Response Relationship, Drug; D005260:Female; D006801:Humans; D008297:Male; D009644:Norgestrel / Q000494:pharmacology; D009929:Organ Size; D010053:Ovary / Q000187:drug effects; D010060:Ovulation / Q000187:drug effects; D011247:Pregnancy / Q000187:drug effects; D011374:Progesterone / Q000494:pharmacology; D011372:Progestins / Q000494:pharmacology*; D011467:Prostate / Q000187:drug effects; D011817:Rabbits; D051381:Rats; D011956:Receptors, Cell Surface; D011960:Receptors, Estrogen; D014599:Uterus / Q000187:drug effects; D014621:Vagina / Q000187:drug effects
D003276:Contraceptives, Oral; D011372:Progestins; D011956:Receptors, Cell Surface; D011960:Receptors, Estrogen; D009644:Norgestrel; D011374:Progesterone